4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001171843-15-005296
VP of Clinical Development sold 22,149 shares at an average $8.88 ($196,664)
- VP of Clinical Development acquired 30,388 shares (option exercise)
- VP of Clinical Development gave up 8,342 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
GOLDBERG Y. PAUL · VP of Clinical Development
Table I: Non-derivative
21 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2015-09-22 | Exercise or conversion : show line 1 in the form | +411 | $5.22 | $2,145 | 6,514 | D |
| 2015-09-22 | Shares withheld for taxes : show line 2 in the form | −198 | $9.53 | $1,887 | 6,316 | D |
| 2015-09-22 | Exercise or conversion : show line 3 in the form | +2,057 | $3.21 | $6,603 | 8,373 | D |
| 2015-09-22 | Shares withheld for taxes : show line 4 in the form | −610 | $9.53 | $5,813 | 7,763 | D |
| 2015-09-22 | Exercise or conversion : show line 5 in the form | +1,028 | $3.77 | $3,876 | 8,791 | D |
| 2015-09-22 | Shares withheld for taxes : show line 6 in the form | −305 | $9.53 | $2,907 | 8,486 | D |
| 2015-09-22 | Exercise or conversion : show line 7 in the form | +5,144 | $3.07 | $15,792 | 13,630 | D |
| 2015-09-22 | Shares withheld for taxes : show line 8 in the form | −1,525 | $9.53 | $14,533 | 12,105 | D |
| Open-market sales · 22,149 sh · avg $8.88 · $196,664 | ||||||
Table II: Derivative
9 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2015-09-22 | Exercise or conversion : show line 22 in the form Stock Option (Right to Buy) | −411 | $5.22 | 2015-12-31 | 411 | 0 | D |
| 2015-09-22 | Exercise or conversion : show line 23 in the form Stock Option (Right to Buy) | −2,057 | $3.21 | 2016-12-31 | 2,057 | 0 | D |
| 2015-09-22 | Exercise or conversion : show line 24 in the form Stock Option (Right to Buy) | −1,028 | $3.77 | 2017-12-31 | 1,028 | 0 | D |
| 2015-09-22 | Exercise or conversion : show line 25 in the form Stock Option (Right to Buy) | −5,144 | $3.07 | 2018-12-31 | 5,144 | 0 | D |
| 2015-09-22 | Exercise or conversion : show line 26 in the form Stock Option (Right to Buy) | −6,172 | $3.56 | 2019-12-31 | 6,172 | 0 | D |
| 2015-09-22 | Exercise or conversion : show line 27 in the form Stock Option (Right to Buy) | −3,703 | $3.52 | 2020-07-01 | 3,703 | 0 | D |
| 2015-09-22 | Exercise or conversion : show line 28 in the form Stock Option (Right to Buy) | −3,115 | $3.73 | 2020-12-01 | 3,115 | 1,000 | D |
| 2015-09-22 | Exercise or conversion : show line 29 in the form Stock Option (Right to Buy) | −7,973 | $2.68 | 2022-12-31 | 7,973 | 4,372 | D |
| 2015-09-22 | Exercise or conversion : show line 30 in the form Stock Option (Right to Buy) | −785 | $2.68 | 2022-12-31 | 785 | 243 | D |
Loading xslF345X03/gff4_goldberg092415.xml…